Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (654)	5/6/2004 4:40:11 PM
From: tuck	Read Replies (1) of 897

I stand somewhat corrected. NKTR/PFE have done extension studies to study the antibody issue. But I don't think they were measuring the post meal glucose profiles at this stage as ARDM/Novo did: pslgroup.com Might be worth trying to get that abstract to see if there is any clarity on that. The docs comments regarding non-relation between antibodies and glucose swings refer to other, shorter trials, I think. A search of the AACE site yielded only an offer to buy an audio tape of the whole meeting for $250. Not the most efficient way to disseminate info. Oh, well. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next